Hematovit iron + bar 30g

Name:
Hematovit Iron Plus bar 30g in pack #1
Description:
The bar, divided into three parts by notches, is dark brown in color, with a characteristic odor, sweet taste. Release form tile Dosage 30 g Indications for use As a therapeutic and prophylactic agent for unbalanced and malnutrition for the prevention of iron deficiency and ascorbic acid. Dosage and administration Inside, after eating 1 part of the tile (24 mg of ascorbic acid, iron (II) ion – 6.7 mg): children 3-6 years old – 1 time per day, children 7-13 years old – 2 times a day a day, adolescents 14-17 years old – 3 times a day, adults – 4 times a day. The duration of use is determined by the doctor individually. Take with caution in case of impaired liver and kidney function, as well as in elderly patients. If you miss another dose of a medicine, do not take a double dose to replace the missed one. Application during pregnancy and lactation Pregnant women and nursing mothers are advised not to exceed the daily requirement for ascorbic acid and iron. During pregnancy, in the postpartum period, the rate of physiological need for ascorbic acid is 90-120 mg per day, iron – 33-38 mg. Precautions The drug should be used with caution in cases of glucose-6-phosphate dehydrogenase deficiency. The drug HEMATOVIT IRON PLUS is not recommended for use simultaneously with other drugs containing ascorbic acid. The drug HEMATOVIT IRON PLUS should not be used in patients with high iron content in the body. The appointment of ascorbic acid to patients with rapidly proliferating and intensively metastasizing tumors can aggravate the course of the process. Ascorbic acid, as a reducing agent, can distort the results of various laboratory tests (blood glucose, bilirubin, activity of “liver” transaminases and LDH). Due to the presence of iron (II) sulfate in the composition of the drug, the drug should be prescribed with caution to patients with gastric and duodenal ulcers, enteritis, ulcerative colitis. 1 dose of the drug (1 part of the tile) contains 6.9 g of sucrose, which must be taken into account in patients with diabetes. It is not recommended for patients with rare congenital fructose intolerance or glucose-galactose malabsorption or sucrase-isomaltase deficiency (see section “Contraindications”). May cause damage to teeth with prolonged use (2 weeks or more). Interaction with other drugs The composition of the drug HEMATOVIT IRON PLUS includes ascorbic acid and iron (II) ion (in the form of iron (II) sulfate monohydrate). Ascorbic acid increases the concentration of benzylpenicillin and tetracyclines in the blood. Improves absorption in the intestines of iron preparations (converts ferric iron to ferrous); May increase iron excretion when used concomitantly with deferoxamine. Reduces the effectiveness of heparin and indirect anticoagulants. Acetylsalicylic acid, oral contraceptives, fresh juices and alkaline drinks reduce the absorption and absorption of ascorbic acid. With simultaneous use with acetylsalicylic acid, the excretion of ascorbic acid in the urine increases and the excretion of acetylsalicylic acid decreases. Increases the risk of developing crystalluria in the treatment of salicylates and short-acting sulfonamides, slows down the excretion of acids by the kidneys, increases the excretion of drugs that have an alkaline reaction (including alkaloids), reduces the concentration of oral contraceptives in the blood. Increases the overall clearance of ethanol, which in turn reduces the concentration of ascorbic acid in the body. With the simultaneous use of ascorbic acid and isoprenaline, the chronotropic effect of isoprenaline decreases. Barbiturates and primidone increase the excretion of ascorbic acid in the urine. Reduces the therapeutic effect of antipsychotic drugs (neurolentic) – phenothiazine derivatives, tubular reabsorption of amphetamine and tricyclic antidepressants. Iron (II) sulfate monohydrate reduces the activity of tetracyclines and D-penicillamine (with combined use in the gastrointestinal tract, poorly absorbed components are formed). Antacids reduce iron resorption. ContraindicationsHemochromatosis, aplastic and hemolytic anemia, leukemia, chronic liver and kidney disease, hyperoxaluria. Hypersensitivity to the components of the drug. Children’s age up to 3 years. The drug should not be taken by persons with lactose and sucrose intolerance (rare congenital galactose intolerance, Lapp lactase deficiency or malabsorption of glucose-galactose, rare congenital fructose intolerance and sucrase-isomaltase deficiency). The drug is contraindicated in patients with diabetes mellitus. Compound one tile: ascorbic acid – 72 mg, iron (II) ion (in the form of iron (II) sulfate monohydrate) – 20 mg; excipients: black food albumin, whole condensed milk with sugar, granulated sugar, caramel starch syrup, vanillin. Overdose HEMATOVIT IRON PLUS contains vitamin C and iron in amounts that pose a low risk of overdose. Symptoms may include signs of an overdose of ascorbic acid and iron. Overdose symptoms occur when using more than 1 g of ascorbic acid per day (more than 14 tablets of the drug HEMATOVIT IRON PLUS). The following symptoms may develop: headache, increased excitability of the central nervous system, insomnia, nausea, vomiting, diarrhea, hyperacid gastritis, ulceration of the mucous membrane of the gastrointestinal tract, inhibition of the function of the insular apparatus of the pancreas (hyperglycemia, glucosuria), hyperoxaluria, nephrolithiasis (from calcium oxalate), damage to the glomerular apparatus of the kidneys, moderate pollakiuria (when taking a dose of more than 600 mg of ascorbic acid per day – 8 tablets of the drug HEMATOVIT IRON PLUS), decreased capillary permeability, increased blood pressure, hypercoagulation, development of microangiopathy, changes in laboratory parameters: thrombocytosis , hyperprothrombinemia, erythropenia, neutrophilic leukocytosis, hypokalemia. Iron supplements are an important cause of accidental overdose in children. 20 mg/kg of elemental iron is sufficient to cause symptoms of toxicity. In the first phase of acute iron overdose, which occurs up to 6 hours after oral administration, signs of gastrointestinal toxicity are observed: nausea, vomiting, severe abdominal pain and diarrhea. Hematemesis and rectal bleeding may occur. Other symptoms include cardiovascular disorders such as hypotension and tachycardia, metabolic changes including acidosis and hyperglycemia, and central nervous system depression ranging from lethargy to coma. In patients with mild to moderate poisoning, symptoms may be limited to this phase only. In severe cases, pronounced hemodynamic disturbances (shock) are noted, acute cerebral insufficiency develops (anxiety, convulsions, coma). The second phase can take place from 6 to 24 hours after taking the drug and is characterized by temporary remission or clinical stabilization. In the third stage, which occurs between 12 and 48 hours after ingestion, gastrointestinal toxicity recurs along with fever, shock, metabolic acidosis, seizures, coma, hepatic necrosis, and jaundice. Hypoglycemia, blood clotting disorders, oliguria or renal failure, pulmonary edema develop. Patients may experience severe lethargy and myocardial dysfunction. The fourth phase may occur several weeks after ingestion and is characterized by gastrointestinal obstruction and possibly late liver injury.” Supportive and symptomatic measures: ensuring airway patency, monitoring heart rate, blood pressure and diuresis, introducing a sufficient amount of fluid to ensure adequate hydration, correcting metabolic acidosis. The use of deferoxamine, if, in addition to nausea, the patient also has other symptoms of an overdose, and the concentration of iron in the blood serum is 3-5 mg / l (55-90 μmol / l) and continues to increase. Hemodialysis cannot effectively remove iron, but should be considered in acute renal failure as it will help remove the iron/deferoxamine complex. Gastric lavage should only be considered within 1 hour of an overdose of a life-threatening amount if the airway can be adequately protected from aspiration. Deferoxamine may be given by mouth or by gastric tube to chelate iron left in the stomach and prevent further absorption after gastric lavage. Activated charcoal is ineffective. In order to eliminate absorbed iron, deferoxamine should be administered intramuscularly or intravenously by slow infusion in case of hypotension or shock to a serum iron level <60 µmol/l. The dose and method of parenteral administration depend on the severity of the poisoning. In case of overdose symptoms, stop taking the drug and consult a doctor. Side effects In rare cases, allergic reactions, irritation of the mucous membrane of the gastrointestinal tract (nausea, vomiting, constipation or diarrhea, staining of excrement in brown-black color, darkening of teeth, abdominal pain), hyperglycemia, glucosuria are possible. If any of the listed side effects occur, or any side effects not listed in the package leaflet, you should consult a doctor. Storage conditions In a place protected from light and moisture at a temperature not exceeding 25 ° C. Keep out of the reach of children. Buy Hematovit iron + bar 30g Price for Hematovit iron + bar 30g Instructions for use for Hematovit iron + bar 30g